Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ Gold
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ Gold
Subscribe
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Checklist Empowers Clinicians to Assess AI in Cancer Care
September 2025
AI is rapidly transforming oncology, but many clinicians lack practical tools to evaluate its real-world reliability.
Read more
18 Sep 2025
New Checklist Empowers Clinicians to Assess AI in Cancer Care
AI is rapidly transforming oncology, but many clinicians lack practical tools to evaluate its real-world reliability.
16 Sep 2025
Chemotherapy Choice Drives Diarrhea Risk in Anal Cancer
Acute diarrhea during chemoradiotherapy for anal cancer is significantly more likely among patients treated with 5-fluorouracil (5-FU) or capecitabine compared with those receiving cisplatin or radiotherapy alone, according to new findings.
14 Sep 2025
MARIPOSA Data Reveal Extended Survival in EGFR Lung Cancer
Overall survival in the Asia cohort of the Phase III MARIPOSA study has been reported to favor amivantamab combined with lazertinib compared with osimertinib monotherapy in patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).
11 Sep 2025
Multiple Barriers Delay Radiation for Head and Neck Cancer
Timely initiation of postoperative radiation therapy (PORT) within 6 weeks of surgery is a critical factor in improving outcomes for patients with head and neck squamous cell carcinoma.
9 Sep 2025
Managing Ocular Side Effects of ADCs in Gynecologic Cancer
Ocular toxicities are an emerging challenge in the management of gynecologic cancers treated with antibody drug conjugates, with new research outlining prevention and care strategies to safeguard patient outcomes.
8 Sep 2025
Treatment Patterns in Mantle Cell Lymphoma: Insights from Japan
A new real-world study has mapped the treatment landscape for mantle cell lymphoma (MCL) in Japan, highlighting common patient characteristics, therapeutic strategies, and ongoing gaps in efficacy and quality of life outcomes.
7 Sep 2025
Payment Incentives Show Modest Impact on Prostate Cancer Testing
Confirmatory testing for men with low-risk prostate cancer increased steadily in recent years, but a payment incentive program was not linked to a statistically significant improvement in its use, according to a large cohort study.
4 Sep 2025
Familiar Surgical Teams Improve Urologic Cancer Outcomes
Greater familiarity among surgical teams significantly improves outcomes in renal, bladder, and prostate cancer procedures, according to a new study assessing team membership and cohesion.
Loading posts...
1
2
3
…
24
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View